Transient Ventricular Tachycardia in Congenital Heart Disease: Extended Monitoring Insights
Overview
In a cohort of 2,805 patients undergoing extended ambulatory cardiac monitoring, nonsustained ventricular tachycardia (NSVT) was detected in 6%, with many episodes identified beyond the initial 48 hours. The study highlights that extended monitoring increases detection rates of NSVT in pediatric and adult patients with congenital heart defects (CHD) and influences clinical management decisions.
Background
Nonsustained ventricular tachycardia (NSVT) is defined as more than 3 consecutive ventricular beats at rates exceeding 120 bpm or 20% above baseline sinus rate lasting less than 30 seconds. It is commonly observed in patients with congenital heart disease (CHD) or cardiomyopathy but is rare in structurally normal hearts of children. Extended ambulatory ECG monitoring devices now allow continuous recording for up to 30 days, improving arrhythmia detection beyond traditional 24–48 hour Holter monitoring. This study investigates the prevalence and clinical implications of NSVT detected by extended monitoring in a pediatric and adult CHD population.
Data Highlights
Parameter
Value
Total patients monitored
2,805
Patients with NSVT
172 (6%)
Second monitor prescribed
113 patients (66%)
NSVT on second monitor
39 patients (35%)
Third monitor prescribed
71 patients (41%)
NSVT on third monitor
23 patients (34%)
Average day of NSVT detection
4.3 ± 3.7 days
Average monitoring duration
7.5 ± 5.5 days
Average NSVT rate
149 ± 34 bpm
Maximum NSVT rate
173 ± 39 bpm
Mean age at NSVT detection
29 ± 14 years (range 3–81)
Patients ≤18 years
22%
Male patients
51%
Key Findings
NSVT was detected in 6% of patients undergoing extended ambulatory monitoring, with many episodes identified after 48 hours.
Repeated monitoring increased detection rates: 35% of patients had NSVT on a second monitor and 34% on a third monitor.
The average time to NSVT detection was approximately 4.3 days, supporting the utility of extended monitoring beyond standard 24–48 hour Holter periods.
NSVT episodes had an average ventricular rate of 149 bpm, with maximum rates reaching 173 bpm.
Patients with CHD or cardiomyopathy were the primary population affected, with 22% of NSVT detections occurring in pediatric patients (≤18 years).
Clinical management changes, including medication adjustments and device implantation, were influenced by NSVT detection on extended monitoring.
Clinical Implications
Extended ambulatory cardiac monitoring significantly improves detection of NSVT in patients with congenital heart defects, especially beyond the initial 48-hour monitoring window. Clinicians should consider prolonged monitoring in this population to better identify arrhythmias that may impact management. Early detection of NSVT can guide timely therapeutic interventions, including medication changes and device implantation, potentially improving patient outcomes.
Conclusion
Extended ambulatory monitoring reveals a higher prevalence of NSVT in pediatric and adult patients with congenital heart disease than previously recognized with standard monitoring durations. This increased detection has important implications for clinical management and supports the use of prolonged monitoring in selected patients.
References
Schultz et al. 2023 -- Extended Monitoring in Adult Congenital Heart Disease
AHA/ACC 2018 -- Guidelines for Management of Adult Congenital Heart Disease
